CHARLES RIVER LABORATORIES (CRL) Stock Analyst Earnings Estimates
NYSE:CRL - New York Stock Exchange, Inc. - US1598641074 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.54B 21.08% | 3.976B 12.31% | 4.129B 3.86% | 4.073B -1.37% | 4.062B -0.27% | 4.318B 6.30% | 4.738B 9.73% | 5.194B 9.62% | 5.956B 14.67% | 6.563B 10.19% | 7.251B 10.48% | 8.021B 10.62% | |
| EBITDA YoY % growth | 898.526M 30.43% | 963.585M 7.24% | 973.446M 1.02% | 1.031B 5.91% | 1.025B -0.58% | 1.113B 8.59% | 1.23B 10.51% | 1.381B 12.28% | 1.6B 15.86% | 1.837B 14.81% | 2.074B 12.90% | 2.343B 12.97% | |
| EBIT YoY % growth | 632.986M 39.42% | 659.715M 4.22% | 659.322M -0.06% | 756.43M 14.73% | 779.65M 3.07% | 857.21M 9.95% | 998.2M 16.45% | 1.095B 9.70% | 1.389B 26.85% | N/A | N/A | N/A | |
| Operating Margin | 17.88% | 16.59% | 15.97% | 18.57% | 19.19% | 19.85% | 21.07% | 21.08% | 23.32% | N/A | N/A | N/A | |
| EPS YoY % growth | 10.33 26.90% | 11.13 7.74% | 10.65 -4.31% | 10.30 -3.27% | 10.35 0.48% | 11.58 11.89% | 13.03 12.49% | 14.61 12.17% | 18.40 25.92% | 26.09 41.77% | 29.52 13.16% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.57 4.36% | 2.41 6.16% | 2.54 -9.23% | 2.67 2.99% | 2.86 11.37% | 2.62 8.69% | 2.82 10.88% | 2.94 10.31% | 3.12 9.22% | 2.72 3.73% | 2.68 -5.02% | 3.24 10.18% |
| Revenue Q2Q % growth | 994.88M -1.83% | 1B -1.14% | 1.018B -0.79% | 1.036B 2.60% | 1.055B 6.04% | 1.059B 5.90% | 1.066B 4.72% | 1.094B 5.60% | 1.119B 6.07% | 1.105B 4.34% | 1.098B 3.00% | 1.172B 7.13% |
| EBITDA Q2Q % growth | 264.43M -43.06% | 255.87M 12.06% | 269.98M -20.84% | 273.56M -32.90% | 280.45M 6.06% | 271.58M 6.14% | 286.64M 6.17% | 296.67M 8.45% | 308.95M 10.16% | 269.58M -0.74% | 267.83M -6.56% | 309.22M 4.23% |
| EBIT Q2Q % growth | 197.52M 31.41% | 191.05M 33.62% | 200.7M 18.33% | 205.33M 38.69% | 216.78M 9.75% | 210.58M 10.22% | 224.37M 11.79% | 226.83M 10.47% | 235.26M 8.52% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 2.59 -4.78% | 2.45 | 0.14 | 5.70% |
| Q2 2024 Q2Q % growth | 2.80 4.09% | 2.42 | 0.38 | 15.80% |
| Q1 2024 Q2Q % growth | 2.27 -18.35% | 2.09 | 0.18 | 8.63% |
| Q4 2023 Q2Q % growth | 2.46 -17.45% | 2.43 | 0.03 | 1.38% |
| Q3 2023 Q2Q % growth | 2.72 3.42% | 2.39 | 0.33 | 13.71% |
| Q2 2023 Q2Q % growth | 2.69 -2.89% | 2.66 | 0.03 | 0.95% |
| Q1 2023 Q2Q % growth | 2.78 1.09% | 2.61 | 0.17 | 6.34% |
| Q4 2022 Q2Q % growth | 2.98 19.68% | 2.77 | 0.21 | 7.46% |
| Q3 2022 Q2Q % growth | 2.63 -2.59% | 2.52 | 0.11 | 4.37% |
| Q2 2022 Q2Q % growth | 2.77 6.13% | 2.76 | 0.01 | 0.30% |
| Q1 2022 Q2Q % growth | 2.75 8.70% | 2.74 | 0.01 | 0.26% |
| Q4 2021 Q2Q % growth | 2.49 4.18% | 2.46 | 0.03 | 1.35% |
| Q3 2021 Q2Q % growth | 2.70 15.88% | 2.60 | 0.10 | 3.70% |
| Q2 2021 Q2Q % growth | 2.61 65.19% | 2.40 | 0.21 | 8.57% |
| Q1 2021 Q2Q % growth | 2.53 37.50% | 2.21 | 0.32 | 14.27% |
| Q4 2020 Q2Q % growth | 2.39 18.91% | 2.13 | 0.26 | 12.40% |
| Q3 2020 Q2Q % growth | 2.33 37.87% | 1.82 | 0.51 | 28.20% |
| Q2 2020 Q2Q % growth | 1.58 -3.07% | 1.28 | 0.30 | 23.72% |
| Q1 2020 Q2Q % growth | 1.84 31.43% | 1.50 | 0.34 | 22.89% |
| Q4 2019 Q2Q % growth | 2.01 | 1.85 | 0.16 | 8.48% |
| Q3 2019 Q2Q % growth | 1.69 | 1.65 | 0.04 | 2.50% |
| Q2 2019 Q2Q % growth | 1.63 | 1.57 | 0.06 | 3.90% |
| Q1 2019 Q2Q % growth | 1.40 | 1.40 | 0.00 | 0.33% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.01B -1.64% | 985.77M | 23.993M | 2.43% |
| Q2 2024 Q2Q % growth | 1.026B -3.19% | 1.035B | -8.883M | -0.86% |
| Q1 2024 Q2Q % growth | 1.012B -1.73% | 1.002B | 9.56M | 0.95% |
| Q4 2023 Q2Q % growth | 1.013B -7.85% | 1.001B | 12.476M | 1.25% |
| Q3 2023 Q2Q % growth | 1.027B 3.79% | 1.011B | 15.623M | 1.55% |
| Q2 2023 Q2Q % growth | 1.06B 8.92% | 1.064B | -4.063M | -0.38% |
| Q1 2023 Q2Q % growth | 1.029B 12.63% | 996.21M | 33.163M | 3.33% |
| Q4 2022 Q2Q % growth | 1.1B 21.52% | 1.045B | 54.843M | 5.25% |
| Q3 2022 Q2Q % growth | 989.157M 10.40% | 980.14M | 9.017M | 0.92% |
| Q2 2022 Q2Q % growth | 973.131M 6.40% | 1.005B | -31.869M | -3.17% |
| Q1 2022 Q2Q % growth | 913.929M 10.83% | 919.21M | -5.281M | -0.57% |
| Q4 2021 Q2Q % growth | 905.05M 14.42% | 897.16M | 7.89M | 0.88% |
| Q3 2021 Q2Q % growth | 895.937M 20.54% | 912.23M | -16.293M | -1.79% |
| Q2 2021 Q2Q % growth | 914.607M 33.99% | 889.25M | 25.357M | 2.85% |
| Q1 2021 Q2Q % growth | 824.6M 16.62% | 806.16M | 18.44M | 2.29% |
| Q4 2020 Q2Q % growth | 791M 14.46% | 764.43M | 26.57M | 3.48% |
| Q3 2020 Q2Q % growth | 743.3M 11.27% | 724.05M | 19.25M | 2.66% |
| Q2 2020 Q2Q % growth | 682.6M 3.80% | 645.71M | 36.89M | 5.71% |
| Q1 2020 Q2Q % growth | 707.1M 16.95% | 697.6M | 9.5M | 1.36% |
| Q4 2019 Q2Q % growth | 691.1M | 692.17M | -1.07M | -0.15% |
| Q3 2019 Q2Q % growth | 668M | 679.76M | -11.76M | -1.73% |
| Q2 2019 Q2Q % growth | 657.6M | 669.14M | -11.54M | -1.72% |
| Q1 2019 Q2Q % growth | 604.6M | 601.62M | 2.98M | 0.50% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -22.95% | 0% | 1.85% |
| Revenue | 0% | -11.49% | 0.02% | 0.92% |